Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fuller H B (FUL) Cash & Equivalents (2016 - 2025)

Fuller H B's Cash & Equivalents history spans 17 years, with the latest figure at $107.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 36.69% year-over-year to $107.2 million; the TTM value through Nov 2025 reached $107.2 million, down 36.69%, while the annual FY2025 figure was $107.2 million, 36.69% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $107.2 million at Fuller H B, down from $122.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $179.5 million in Q4 2023 and bottomed at $60.7 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $100.0 million (2023), against an average of $103.5 million.
  • The largest annual shift saw Cash & Equivalents tumbled 38.54% in 2021 before it soared 124.57% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $61.8 million in 2021, then rose by 29.33% to $79.9 million in 2022, then surged by 124.57% to $179.5 million in 2023, then dropped by 5.63% to $169.4 million in 2024, then tumbled by 36.69% to $107.2 million in 2025.
  • Per Business Quant, the three most recent readings for FUL's Cash & Equivalents are $107.2 million (Q4 2025), $122.5 million (Q3 2025), and $96.8 million (Q2 2025).